http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Thermal and Dynamic-Mechanical Characterization of Rice-Husk Filled Polypropylene Composites
Rosa, Simone M.L.,Nachtigall, Sonia M.B.,Ferreira, Carlos A. The Polymer Society of Korea 2009 Macromolecular Research Vol.17 No.1
Natural fiber-filled polymer composites have attracted great interest due to increasing environmental concerns and their low costs. In this study, the properties of rice husk flour-filled polypropylene (PP) were analysed in view of the large quantities of this agricultural product available as residue in Brazil. The rice husk flour (RHF) was characterized by SEM and particle size distribution. The properties of the composites were studied by MFI, DMA, DSC and TGA analyses. A commercial PP modified with maleic anhydride (MAPP) was used as coupling agent. It was verified that RHF decreased the MFI of the composites and that the coupling agent decreased it even more. The efficiency of MAPP was confirmed by the high storage modulus and high loss factor of the coupled composites.
Review : Menopausal Hormone Treatment and the Progression of Vascular Disease
( Seung Do Choi ),( Margaret J Nachtigall ),( Emma M Steinberg ),( Hae Hyeog Lee ),( Frederick Naftolin ) 대한폐경학회 2010 대한폐경학회지 Vol.16 No.2
Observational studies and laboratory research support cardioprotective effects of menopausal hormone treatment (MHT). However, cardioprotective effects of MHT were not confirmed by randomized clinical studies that were made up of subjects who were well-beyond the time of menopausal symptoms and were of advanced chronological age when they began hormone treatment (HT). The differences in study outcomes most likely reflect age-related differences in cardiovascular risk factors such as hypertension and metabolic syndromes. As well, data from the randomized clinical trial (RCT)s confirmed the presence of actual cardiovascular disease (CVD) in many of the RCT subjects prior to beginning HT. Therefore, beginning MHT early seems crucial since older women are at greater risk for the presence of risk factors and sub-clinical CVD. Older women also are possible targets of hormonally related thrombosis because of their underlying vascular disease. The need for early prophylaxis is convenient since most women seek treatment for symptoms within the first few years of menopause. This review addresses issues regarding optimization of the initiation of MHT for cardioprotection.